IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation

Journal of the American Society of Nephrology

Volumn 21, Issue 1, 2010, Pages 189-197

  Hall, Isaac E ^a,b   Yarlagadda, Sri G ^c   Coca, Steven G ^a,b   Wang, Zhu ^a,b   Doshi, Mona ^d   Devarajan, Prasad ^e   Han, Won K ^f   Marcus, Richard J ^g   Parikh, Chirag R ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^f THOMAS JEFFERSON UNIVERSITY   (United States)

^g DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; INTERLEUKIN 18; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ADULT; ARTICLE; COLD ISCHEMIA; CONTROLLED STUDY; CONVALESCENCE; FEMALE; FOLLOW UP; HUMAN; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; RENAL REPLACEMENT THERAPY; URINE VOLUME;

EID: 75149180130     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009030264     Document Type: Article

References (54)

1. Halloran PF, Hunsicker LG: Delayed graft function: State of the art, November 10-11, 2000. Summit meeting, Scottsdale, Arizona, USA. Am J Transplant 1: 115-120, 2001
2. El-Maghraby TA, Boom H, Camps JA, Blokland KA, Zwinderman AH, Paul LC, Pauwels EK, De Fijter JW: Delayed graft function is characterized by reduced functional mass measured by (99m)Technetiummercaptoacetyltriglycine renography. Transplantation 74: 203-208, 2002
3. Rodrigo E, Ruiz JC, Pinera C, Fernandez-Fresnedo G, Escallada R, Palomar R, Cotorruelo JG, Zubimendi JA, Martin de Francisco AL, Arias M: Creatinine reduction ratio on post-transplant day two as criterion in defining delayed graft function. Am J Transplant 4: 1163-1169, 2004
4. Mikhalski D, Wissing KM, Ghisdal L, Broeders N, Touly M, Hoang AD, Loi P, Mboti F, Donckier V, Vereerstraeten P, Abramowicz D: Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression. Transplantation 85: S3-S9, 2008
5. Keitel E, Michelon T, dos Santos AF, Bittar AE, Goldani JC, D'Almeida Bianco P, Bruno RM, Losekann A, Messias AA, Bender D, Bianchini JJ, Duro Garcia V: Renal transplants using expanded cadaver donor criteria. Ann Transplant 9: 23-24, 2004
6. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S: High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 333: 333-336, 1995
7. Moers C, Smits JM, Maathuis MH, Treckmann J, van Gelder F, Napieralski BP, van Kasterop-Kutz M, van der Heide JJ, Squifflet JP, van Heurn E, Kirste GR, Rahmel A, Leuvenink HG, Paul A, Pirenne J, Ploeg RJ: Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 360: 7-19, 2009
8. Rosenthal JT, Danovitch GM, Wilkinson A, Ettenger RB: The high cost of delayed graft function in cadaveric renal transplantation. Transplantation 51: 1115-1118, 1991
9. Almond PS, Troppmann C, Escobar F, Frey DJ, Matas AJ, Rosenthal JT, Danovitch GM, Wilkinson A, Ettenger RB: Economic impact of delayed graft function. Transplant Proc 23: 1304, 1991
10. Yarlagadda SG, Coca SG, Formica RN, Jr., Poggio ED, Parikh CR: Association between delayed graft function and allograft and patient survival: A systematic review and meta-analysis. Nephrol Dial Transplant 24: 1039-1047, 2008
11. Humar A, Ramcharan T, Kandaswamy R, Gillingham K, Payne WD, Matas AJ: Risk factors for slow graft function after kidney transplants: A multivariate analysis. Clin Transplant 16: 425-429, 2002
12. Johnston O, O'Kelly P, Spencer S, Donohoe J, Walshe JJ, Little DM, Hickey D, Conlon PJ: Reduced graft function (with or without dialysis) vs immediate graft function-A comparison of long-term renal allograft survival. Nephrol Dial Transplant 21: 2270-2274, 2006
13. Boom H, Mallat MJ, de Fijter JW, Zwinderman AH, Paul LC: Delayed graft function influences renal function, but not survival. Kidney Int 58: 859-866, 2000
14. Giral-Classe M, Hourmant M, Cantarovich D, Dantal J, Blancho G, Daguin P, Ancelet D, Soulillou JP: Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys. Kidney Int 54: 972-978, 1998
15. Humar A, Johnson EM, Payne WD, Wrenshall L, Sutherland DE, Najarian JS, Gillingham KJ, Matas AJ: Effect of initial slow graft function on renal allograft rejection and survival. Clin Transplant 11: 623-627, 1997
16. Marcen R, Orofino L, Pascual J, de la Cal MA, Teruel JL, Villafruela JJ, Rivera ME, Mampaso F, Burgos FJ, Ortuno J: Delayed graft function does not reduce the survival of renal transplant allografts. Transplantation 66: 461-466, 1998
17. Perez Fontan M, Rodriquez-Carmona A, Bouza P, Garcia Falcon T, Moncalian J, Oliver J, Valdes F: Outcome of grafts with long-lasting delayed function after renal transplantation. Transplantation 62: 42-47, 1996
18. Daly PJ, Power RE, Healy DA, Hickey DP, Fitzpatrick JM, Watson RW: Delayed graft function: a dilemma in renal transplantation. BJU Int 96: 498-501, 2005
19. Hirschberg R, Kopple J, Lipsett P, Benjamin E, Minei J, Albertson T, Munger M, Metzler M, Zaloga G, Murray M, Lowry S, Conger J, McKeown W, O'Shea M, Baughman R, Wood K, Haupt M, Kaiser R, Simms H, Warnock D, Summer W, Hintz R, Myers B, Haenftling K, Capra W, Pike M, Guler H: Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int 55: 2423-2432, 1999
20. Coca SG, Yalavarthy R, Concato J, Parikh CR: Biomarkers for the diagnosis and risk stratification of acute kidney injury: A systematic review. Kidney Int 73: 1008-1016, 2008
21. Zhang J, Yu KF: What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280: 1690-1691, 1998
22. Pencina MJ, D'Agostino RB, Sr., D'Agostino RB, Jr., Vasan RS: Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med 27: 157-172, 2008
23. Parikh CR, Jani A, Mishra J, Ma Q, Kelly C, Barasch J, Edelstein CL, Devarajan P: Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 6: 1639-1645, 2006
24. Devarajan P, Mishra J, Supavekin S, Patterson LT, Steven Potter S: Gene expression in early ischemic renal injury: Clues towards pathogenesis, biomarker discovery, and novel therapeutics. Mol Genet Metab 80: 365-376, 2003
25. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P: Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14: 2534-2543, 2003
26. Mishra J, Mori K, Ma Q, Kelly C, Yang J, Mitsnefes M, Barasch J, Devarajan P: Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 15: 3073-3082, 2004
27. Jordan JA, Guo RF, Yun EC, Sarma V, Warner RL, Crouch LD, Senaldi G, Ulich TR, Ward PA: Role of IL-18 in acute lung inflammation. J Immunol 167: 7060-7068, 2001
28. Plater-Zyberk C, Joosten LA, Helsen MM, Sattonnet-Roche P, Siegfried C, Alouani S, van De Loo FA, Graber P, Aloni S, Cirillo R, Lubberts E, Dinarello CA, van Den Berg WB, Chvatchko Y: Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis. J Clin Invest 108: 1825-1832, 2001
29. Siegmund B, Fantuzzi G, Rieder F, Gamboni-Robertson F, Lehr HA, Hartmann G, Dinarello CA, Endres S, Eigler A: Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production. Am J Physiol Regul Integr Comp Physiol 281: R1264-R1273, 2001
30. Pomerantz BJ, Reznikov LL, Harken AH, Dinarello CA: Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1beta. Proc Natl Acad Sci U S A 98: 2871-2876, 2001
31. Melnikov VY, Ecder T, Fantuzzi G, Siegmund B, Lucia MS, Dinarello CA, Schrier RW, Edelstein CL: Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest 107: 1145-1152, 2001
32. Melnikov VY, Faubel S, Siegmund B, Lucia MS, Ljubanovic D, Edelstein CL: Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice. J Clin Invest 110: 1083-1091, 2002
33. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365: 1231-1238, 2005
34. Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL: Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 16: 3046-3052, 2005
35. Parikh CR, Mishra J, Thiessen-Philbrook H, Dursun B, Ma Q, Kelly C, Dent C, Devarajan P, Edelstein CL: Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 70: 199-203, 2006
36. Wagener G, Jan M, Kim M, Mori K, Barasch JM, Sladen RN, Lee HT: Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 105: 485-491, 2006
37. Washburn KK, Zappitelli M, Arikan AA, Loftis L, Yalavarthy R, Parikh CR, Edelstein CL, Goldstein SL: Urinary interleukin-18 is an acute kidney injury biomarker in critically ill children. Nephrol Dial Transplant 23: 566-572, 2007
38. Zappitelli M, Washburn KK, Arikan AA, Loftis L, Ma Q, Devarajan P, Parikh CR, Goldstein SL: Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: A prospective cohort study. Crit Care 11: R84, 2007
39. Cundy TF, Nixon D, Berkahn L, Baker J: Measuring the albumin excretion rate: Agreement between methods and biological variability. Diabet Med 9: 138-143, 1992
40. Lakatua DJ, Blomquist CH, Haus E, Sackett-Lundeen L, Berg H, Swoyer J: Circadian rhythm in urinary N-acetyl-beta-glucosaminidase (NAG) of clinically healthy subjects. Timing and phase relation to other urinary circadian rhythms. Am J Clin Pathol 78: 69-77, 1982
41. Trachtenberg F, Barregard L, McKinlay S: The influence of urinary flow rate in children on excretion of markers used for assessment of renal damage: Albumin, gamma-glutamyl transpeptidase, N-acetyl-beta-Dglucosaminidase, and alpha1-microglobulin. Pediatr Nephrol 23: 445-456, 2008
42. Han WK, Waikar SS, Johnson A, Betensky RA, Dent CL, Devarajan P, Bonventre JV: Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int 73: 863-869, 2008
43. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV: Kidney injury molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney Int 62: 237-244, 2002
44. Han WK, Alinani A, Wu CL, Michaelson D, Loda M, McGovern FJ, Thadhani R, Bonventre JV: Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma. J Am Soc Nephrol 16: 1126-1134, 2005
45. Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL, Sanicola M: Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 273: 4135-4142, 1998
46. Zhang PL, Rothblum LI, Han WK, Blasick TM, Potdar S, Bonventre JV: Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury. Kidney Int 73: 608-614, 2008
47. van Timmeren MM, Vaidya VS, van Ree RM, Oterdoom LH, de Vries AP, Gans RO, van Goor H, Stegeman CA, Bonventre JV, Bakker SJ: High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. Transplantation 84: 1625-1630, 2007
48. UNOS Database. Available online at http://www.optn.org/latestData/ step2.asp. Please provide authoring group and date of access.
49. Hariharan S, Alexander JW, Schroeder TJ, First MR: Impact of first acute rejection episode and severity of rejection on cadaveric renal allograft survival. Clin Transplant 10: 538-541, 1996
50. Land WG: The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation. Transplantation 79: 505-514, 2005
51. Pepe MS, Feng Z, Janes H, Bossuyt PM, Potter JD: Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design. J Natl Cancer Inst 100: 1432-1438, 2008
52. Perico N, Cattaneo D, Sayegh MH, Remuzzi G: Delayed graft function in kidney transplantation. Lancet 364: 1814-1827, 2004
53. Parikh CR, Garg AX: Acute kidney injury: Better biomarkers and beyond. Kidney Int 73: 801-803, 2008
54. Shibata M, Hirota M, Nozawa F, Okabe A, Kurimoto M, Ogawa M: Increased concentrations of plasma IL-18 in patients with hepatic dysfunction after hepatectomy. Cytokine 12: 1526-1530, 2000